Medivir announces the outcome of the directed share issue which was announced on 22 January 2024
7,547,170 shares were issued, and all shares have been subscribed for by and allotted to Hallberg Management AB in accordance with the resolution regarding the share issue. The subscription price wasSEK 2.65 which means that Medivir receives issue proceeds of approximately SEK 20 million before deductions of costs related to the issue. For more information about the directed issue, see the separate press release published on 22 January 2024. For additional information, please contact; Magnus Christensen, CFO, Medivir AB Telephone: +46 8 5468 3100 E-mail: magnus.